Latest News - Allergan

Tuesday, October 03, 2017 | FDA Approval/Clearance, Allergan

FDA Adds Third Approved Indication for Botox Cosmetic: Forehead Lines

Allergan plc's Botox Cosmetic received ts third FDA indication -- the temporary improvement in the appearance of moderate to severe forehead lines associated with frontalis muscle activity in adul…

Read the full story

Tuesday, September 12, 2017 | Personnel/Company News, PracticalDermatology.com, Product Launches and Updates, Allergan , SkinMedica, Zeltiq

Allergan Adds Coolsculpting, Other Bells and Whistles to Brilliant Distinctions® Patient Loyalty Program

Allergan is launching the next generation of its U.S.-based Brilliant Distinctions® program. The new offering incorporates digital innovation to enhance the consumer experience and drive increa…

Read the full story

Friday, September 08, 2017 | Personnel/Company News, PracticalDermatology.com, Allergan

Deion Sanders Named Brand Ambassador for Botox Cosmetic

NFL analyst and philanthropist Deion Sanders, the only athlete to play in both the Super Bowl™ and World Series™, is the new brand ambassador for BOTOX® Cosmetic. Allergan…

Read the full story

Tuesday, July 25, 2017 | Acquisitions and Mergers, PracticalDermatology.com, Allergan , SkinMedica, Suneva

Histogen’s Growth Factor Technology Now Part of Allergan's Skin Care Line

Histogen’s growth factor technology will be marketed as part of Allergan's skin care line within its recently acquired Regenica® Advanced Rejuvenation System. The Regenica line is bas…

Read the full story

Wednesday, July 19, 2017 | Personnel/Company News, Allergan

Joseph H. Boccuzi Appointed to Allergan plc Board of Directors

Allergan plc has named Joseph H. Boccuzi to its Board of Directors, effective immediately.  Mr. Boccuzi recently retired as a Partner in the Global Life Sciences, Board and Chief Executive Office…

Read the full story

Wednesday, July 12, 2017 | Personnel/Company News, PracticalDermatology.com, Allergan

Allergan CEO: Consensus Needed on Medical Aesthetic Treatment in Minors

Allergan Chairman & CEO Brent Saunders, the father of two high school-aged girls, is speaking up and out about the risks associated with offering medical aesthetic treatments to minors. In a ne…

Read the full story

Wednesday, May 24, 2017 | PracticalDermatology.com, Product Launches and Updates, Allergan

Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE

Emmy and Tony award-winning actress and singer Kristin Chenoweth is kicking off  Allergan’s Rhofade "Less Red, More You" campaign. Chenoweth, who has rosacea, will begin a nati…

Read the full story

Friday, April 28, 2017 | Acquisitions and Mergers, Allergan , Cool Sculpting, Zeltiq

Allergan Officially Adds Coolsculpting to Portfolio

It’s a done deal. Allergan now owns ZELTIQ® Aesthetics. Allergan acquired ZELTIQ® Aesthetics for approximately $2.4 billion in cash. ZELTIQ® stockholders approved the transa…

Read the full story

Thursday, April 06, 2017 | Personnel/Company News, Allergan

Allergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy

Daphne Karydas is Allergan’s new Senior Vice President of Global Investor Relations and Strategy, effective April 17, 2017.   In this role, Ms. Karydas will lead the Company's engage…

Read the full story

Thursday, April 06, 2017 | Acquisitions and Mergers, Allergan , Zeltiq

Business News: Allergan and ZELTIQ Announce Expiration of HSR Waiting Period for Pending Transaction

Allergan is now one step closer to officially acquiring Zeltiq. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") has expired with res…

Read the full story

Monday, March 27, 2017 | Phase 3/4 Trials, PracticalDermatology.com, Research and Publications, Allergan

Allergan and Paratek Pharmaceuticals' Acne Drug Performs Well in Phase 3 Trials

Allergan and Paratek Pharmaceuticals, Inc.’s investigational acne drug performed well in two Phase 3 studies, the companies report. Sarecycline, a once-daily, oral, narrow spectrum tetracycli…

Read the full story

Monday, March 20, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Allergan

FDA Approved Juvéderm Vollure XC for Correction of Facial Wrinkles and Folds

The FDA has approved Allergan plc's Juvéderm Vollure XC for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21. In the US piv…

Read the full story

Tuesday, March 14, 2017 | PracticalDermatology.com, Allergan

Survey Findings: Submental Region Major Pain Point for Patients

Close to 50 percent of individuals are bothered by the appearance of the area under their chin, and many alter their behavior as a result, according to a new survey commissioned by Allergan plc. …

Read the full story

Tuesday, February 14, 2017 | Acquisitions and Mergers, PracticalDermatology.com, Allergan , Cool Sculpting, Cynosure, PicoWay, Profound, Syneron, Tattoo , Zeltiq

Rumor Has It Syneron Is Next In Week of Surprising Aquisitions

Hot off the heels of Allergan’s acquisition of Zeltiq and Hologic Inc,’s surprising purchase of Cynosure Inc., media reports are now swirling that British private equity fund Apax Partners…

Read the full story

Monday, February 13, 2017 | Acquisitions and Mergers, PracticalDermatology.com, Allergan , Cool Sculpting, Zeltiq

Allergan to Acquire ZELTIQ for $2.47 Billion

Allergan plc  and ZELTIQ® Aesthetics, Inc. have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 …

Read the full story
Load More